NCT04790838View on ClinicalTrials.gov

Pooled Analysis FP_SX_250_50

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

June 2, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Asthma
Interventions
DRUG

Test

2 inhalations of Test and Reference product in each study period

DRUG

Reference

2 inhalations of Test and Reference product in each study period

Trial Locations (1)

41100

BECRO Clinical Facility, Larissa

All Listed Sponsors
collaborator

Becro Ltd.

INDUSTRY

lead

Respirent Pharmaceuticals Co Ltd.

INDUSTRY

NCT04790838 - Pooled Analysis FP_SX_250_50 | Biotech Hunter | Biotech Hunter